Published:
The Journal of Clinical Pharmacology
Date:
Abstract:
This study assessed the single- and multiple-dose pharmacokinetics of 3
doses (15 mg, 30 mg, and 45 mg) of pioglitazone in 36 adolescents with type
2 diabetes.